Dopaminergic regulation of glucose-induced insulin secretion through dopamine D2 receptors in the pancreatic islets in vitro

IUBMB Life

Volumn 58, Issue 3, 2006, Pages 157-163

  Shankar, Eswar ^a,b   Santhosh, K T ^a   Paulose, C S ^a  

^a Department of Physics   (India)

^b UNIVERSITY OF NORTH TEXAS   (United States)

Author keywords

Diabetes; Dopamine; Dopamine D2 receptors; Insulin secretion; Neurotransmitters; Norepinephrine; Pancreatic islets

Indexed keywords

BUTACLAMOL; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; GLUCOSE; INSULIN; NORADRENALIN; SULPIRIDE;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; DOPAMINE RECEPTOR BLOCKING; DOPAMINE UPTAKE; DOPAMINERGIC ACTIVITY; HORMONAL REGULATION; IN VITRO STUDY; INSULIN RELEASE; MALE; NEUROMODULATION; NONHUMAN; PANCREAS ISLET; PARACRINE SIGNALING; PATHOPHYSIOLOGY; RAT;

ANIMALS; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; GLUCOSE; INSULIN; ISLETS OF LANGERHANS; MALE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; TISSUE CULTURE TECHNIQUES;

ANIMALIA;

EID: 33646857967     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1080/15216540600687993     Document Type: Article

References (32)

1. Schuit, F. C. (1996) Factors determining the glucose sensitivity and glucose responsiveness of pancreatic beta cells. Horm. Res. 46, 99-106.
2. 2+ stores and plasma membrane ion channels. Curr. Opin. Endocrinol. Diabetes 4, 262-271.
3. Renstrom, E., Ding, W. G., Bokvist, K., and Rorsman, P. (1996) Neurotransmitter induced inhibition of exocytosis in insulin secretory beta cells by activation of calcineurin. Neurone 17, 513-522.
4. Porte, J. D. (1967) A receptor mechanism for the inhibition of insulin release by epinephrine in man. J. Clin. Invest. 46, 86-94.
5. Lacey, R. J., Cable, C. H., James, R. F., London, M. J. M., Peirett, C. W., Scarpello, J. H., and Morgan, N. G. (1993) Concentration dependent effect of adrenalin on the profile of insulin secretion from isolated human islets of langerhans. J. Endicrinol. 138, 555-563.
6. Filipponi, P., Gregorio, F., Ferrandina, C., Nicoletti, I., Mannareli, C., Pippi, R., and Santeusanio, F. (1986) Alpha-adrenergic system in the modulation of pancreatic A and B cell function in normal rats. Diabetes Res. Clin. Pract. 2, 325-336.
7. Alef, N., Lofontan, M., Double A., Helary, C., Ktorza, A., and Penicaud, L. (1996) A specific beta-3 adereno receptor agonist induces increased pancreatic islet blood flow and insulin secretion in rats. Eur. J. Pharmacol. 298, 287-292.
8. Smith, P. H., and Davis, B. J. (1985) Effect of substantia nigra lesions on the volume of A, B, and D cells and the content of insulin and glucagon in the rat pancreas. Diabetologia 28, 756-762.
9. Swanson, L. W., and Sawchenko, P. E. (1980) Paraventricular nucleus: a site for the integration of neuroendocrine and autonomic mechanisms. Neuroendocrinology 31, 410-417.
10. 2+ efflux and insulin secretion in isolated rat islets. Pharmacology 30, 71-82.
11. Ahren, B., Jarhult, J., and Lundquist, I. (1981) Influence of the sympatheto-adrenal system and somatostatin on the secretion of insulin in the rat. J. Physiol. 312, 563-575.
12. Takeuchi, S. O. T., Shonai, K., and Imamura, S. (1990) Distribution of catecholaminergic receptors in the rat's pancreas islet. Nippon Ika Daigaku Zasshi 57, 119-126.
13. Howell, S. L., and Taylor, K. W. (1968) Potassium ion and the secretion of insulin by islets of langerhans incubated in vitro. Biochem. J. 108, 17-24.
14. Pipeleers, D. G., Veld, I. P. A., Dewinkle, V. M., Maes, E., Schuits, F. C., and Gepts, W. (1985) A new in vitro model for the study of pancreatic A and B cells. Endocrinology 117, 806-816.
15. 2+ efflux by dopamine in glucose-stimulated pancreatic islets. Gen. Pharmacol. 25, 909-916.
16. Schuit, F. C., Huypens. P., Heimberg. H., and Pipeleers, D. G. (2001) Glucose sensing in pancreatic beta-cells: a model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus. Diabetes 50, 1-11.
17. Adeghate, E., Ponery, A. S., and Sheen, R. (2001) Streptozotocin-induced diabetes mellitus is associated with increased pancreatic tissue levels of noradrenalin and adrenaline in rats. Pancreas 22, 311-316.
18. Zern, R. T., Bird, J. L., and Feldman, J. M. (1980) Effect of increased pancreatic islet norepinephrine, dopamine and serotonin concentration on insulin secretion in the golden hamster. Diabetologia 18, 341-346.
19. Abraham, A. (1998) Adrenergic receptors and monoamines in the brain and pancreatic islets of streptozotocin diabetic rats: role of insulin secretion as a function of age. PhD Thesis, Dept. of Biotechnology, Cochin University of Science and Technology, 74-75.
20. A receptors enhances hepatic glucose production and peripheral glucose uptake. Brain Res. Bull. 37, 611-616.
21. Kerstin, U. M., Ahlenius, S., Alster P., and Hillegaart V. (1996) Effective of selective serotonin and dopamine agonist on plasma levels of glucose, insulin and glucagons. Neuroendocrinology 63, 269-274.
22. Eisenhofer, G., Smolich, J. J., and Esler, M. D. (1992) Disposition of endogeneous adrenaline compared to noreadrenaline released by cardiac sympathetic nerves in the anaesthetized dogs. Naunyn Schmiedebergs Arch. Pharmacol. 345, 160-171.
23. Siegel, E. G., Wollheim, C. B., Kikuchi, M., Renold, A. E., and Sharp, G. W. (1980) Dependency of cyclic AMP-induced insulin release on intra-and extra cellular calcium in rats islets of langerhans, J. Clin. Investi. 65, 233-241.
24. +)/calmodulin-dependent protein kinase II and brain-derived neurotropic factor gene expression by stimulation of dopamine D2 receptor in transfected NG 108-15 cells. J. Neurochem. 82(2), 316-328.
25. Morgan, N. G., and Montague, W. (1985) Studies on the mechanism of inhibition of glucose induced insulin secretion by noradrenalin in rat islets of langerhans. Biochem. J. 226, 571-576.
26. Blanca, R., Ljubicic, S., Pournourmohammadi, S., Carobbio, S., Armanet, M., Bartley, C., and Maechler, P. (2005) Dopamine D2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion. J. Biol. Chem. 280, 36824-36832.
27. Arneric, S. P., Chow, S. A., Long, J. P., and Fischer, L. J. (1984) Inhibition of insulin release from rat pancreatic islets by drugs that are analogues of dopamine. Diabetes 33, 888-893.
28. Mezey, E., Eisenhofer, G., Harta, G., Hansson, S., Gould, L., Hunyady, B., and Hoffman, B. J. (1996) A novel nonneuronal catecholaminergic system: exocrine pancreas synthesizes and releases dopamine. PNAS 93, 10377-10382.
29. 2+ efflux and insulin secretion in isolated rat islets. Pharmacology 30, 71-82.
30. Borelli, M. I., Villar, M. J., Orezzoli, A., and Gagliardino, J. J. (1997) Presence of DOPA decarboxylase and its localisation in adult rat pancreatic islet cells. Diabetes Metab. 23, 161-163.
31. Takayanagi, M., and Watanabe, T. (1996) Immunocytochemical colocalizations of insulin, aromatic L-amino acid decarboxylase, dopamine beta-hydroxylase, S-100 protein and chromogranin A in B-cells of the chicken endocrine pancreas. Tissue Cell 28, 17-24.
32. Ericson, L. E., Hakanson, R., and Lundquist, I. (1977) Accumulation of dopamine in mouse pancreatic B-cells following injection of L-DOPA. Localization to secretory granules and inhibition of insulin secretion. Diabetologia 13, 117-124.